Preliminary Results, Trading Update & Board Change | 01-May-2024 | 07:00 | RNS |
Notice of Results | 30-Apr-2024 | 07:00 | RNS |
COG spin-out Monument Therapeutics accesses ... | 23-Apr-2024 | 07:00 | RNS |
Total Voting Rights and Block Listing Return | 02-Apr-2024 | 16:20 | RNS |
Formation of new Scientific Advisory Board | 21-Mar-2024 | 07:00 | RNS |
Holding(s) in Company | 21-Feb-2024 | 10:16 | RNS |
Cambridge Cognition and ActiGraph Partnership | 21-Feb-2024 | 07:00 | RNS |
Director/PDMR Share Purchases | 30-Jan-2024 | 16:20 | RNS |
Board appointments | 30-Jan-2024 | 07:00 | RNS |
Trading Update | 30-Jan-2024 | 07:00 | RNS |
Grant of Options | 18-Dec-2023 | 07:00 | RNS |
Total Voting Rights | 01-Dec-2023 | 07:00 | RNS |
Change of Auditor | 22-Nov-2023 | 07:00 | RNS |
Total Voting Rights | 01-Nov-2023 | 07:00 | RNS |
Automated quality assurance for clinical trials | 24-Oct-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 48.81p |
Change Today | 0.31p |
% Change | 0.64 % |
52 Week High | 104.00 |
52 Week Low | 48.50 |
Volume | 0 |
Shares Issued | 35.15m |
Market Cap | £17.16m |
RiskGrade | 282 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
0 @ 0.000p |
Chair | Steven John Powell |
CEO | Matthew Stork |
CFO | Stephen Symonds |
You are here: research